Literature DB >> 3510087

Is catch-22 alive and well and living at NHLBI? Reactions to 'digitalis--a new controversy regarding an old drug'.

J L Fleiss, J T Bigger, L M Rolnitzky.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3510087     DOI： 10.1161/01.cir.73.1.19

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

Review 1.  Drug treatment of heart failure.

Authors:  P A Poole-Wilson
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Selective updates on mechanisms of action of positive inotropic agents.

Authors:  G Grupp
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

3.  Digoxin--doubts to dampen enthusiasm.

Authors:  P A Poole Wilson
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

4.  Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.

Authors:  J Leor; U Goldbourt; S Behar; V Boyko; H Reicher-Reiss; E Kaplinsky; B Rabinowitz
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

5.  Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. The SPRINT Study Group.

Authors:  J Leor; U Goldbourt; B Rabinowitz; H Reicher-Reiss; V Boyko; E Kaplinsky; S Behar
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

Review 6.  Digoxin is effective, but is it safe?

Authors:  F I Marcus
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

Review 7.  Digoxin--a redundant drug in congestive cardiac failure.

Authors:  P A Poole-Wilson; K Robinson
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.